NCT00003427: Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
|
|
| Completed | 1 | 36 | US | irinotecan hydrochloride, oxaliplatin | Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI) | Anal Cancer, Colorectal Cancer, Esophageal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Carcinoid Tumor, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer | 04/02 | 04/02 | | |
